U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H23N5O.2H3O4P
Molecular Weight 569.4413
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MOTESANIB DIPHOSPHATE

SMILES

OP(O)(O)=O.OP(O)(O)=O.CC1(C)CNC2=C1C=CC(NC(=O)C3=CC=CN=C3NCC4=CC=NC=C4)=C2

InChI

InChIKey=ONDPWWDPQDCQNJ-UHFFFAOYSA-N
InChI=1S/C22H23N5O.2H3O4P/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15;2*1-5(2,3)4/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28);2*(H3,1,2,3,4)

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
MOTESANIB DIPHOSPHATE
MART.   MI   USAN   WHO-DD  
USAN  
Official Name English
MOTESANIB PHOSPHATE
JAN  
Common Name English
MOTESANIB DIPHOSPHATE [MI]
Common Name English
3-PYRIDINECARBOXAMIDE, N-(2,3-DIHYDRO-3,3-DIMETHYL-1H-INDOL-6-YL)-2-((4-PYRIDINYLMETHYL)AMINO)-, PHOSPHATE (1:2)
Systematic Name English
MOTESANIB DIPHOSPHATE [USAN]
Common Name English
MOTESANIB PHOSPHATE [JAN]
Common Name English
Motesanib diphosphate [WHO-DD]
Common Name English
MOTESANIB DIPHOSPHATE [MART.]
Common Name English
N-(3,3-DIMETHYL-2,3-DIHYDRO-1H-INDOL-6-YL)-2-((PYRIDIN-4-YLMETHYL)AMINO)NICOTINAMIDE BIS(PHOSPHATE)
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C1967
Created by admin on Fri Dec 15 17:20:55 UTC 2023 , Edited by admin on Fri Dec 15 17:20:55 UTC 2023
FDA ORPHAN DRUG 197104
Created by admin on Fri Dec 15 17:20:55 UTC 2023 , Edited by admin on Fri Dec 15 17:20:55 UTC 2023
Code System Code Type Description
SMS_ID
100000124320
Created by admin on Fri Dec 15 17:20:55 UTC 2023 , Edited by admin on Fri Dec 15 17:20:55 UTC 2023
PRIMARY
ChEMBL
CHEMBL572881
Created by admin on Fri Dec 15 17:20:55 UTC 2023 , Edited by admin on Fri Dec 15 17:20:55 UTC 2023
PRIMARY
USAN
SS-23
Created by admin on Fri Dec 15 17:20:55 UTC 2023 , Edited by admin on Fri Dec 15 17:20:55 UTC 2023
PRIMARY
EPA CompTox
DTXSID30235080
Created by admin on Fri Dec 15 17:20:55 UTC 2023 , Edited by admin on Fri Dec 15 17:20:55 UTC 2023
PRIMARY
FDA UNII
T6Q3060U91
Created by admin on Fri Dec 15 17:20:55 UTC 2023 , Edited by admin on Fri Dec 15 17:20:55 UTC 2023
PRIMARY
MESH
C519562
Created by admin on Fri Dec 15 17:20:55 UTC 2023 , Edited by admin on Fri Dec 15 17:20:55 UTC 2023
PRIMARY
EVMPD
SUB32098
Created by admin on Fri Dec 15 17:20:55 UTC 2023 , Edited by admin on Fri Dec 15 17:20:55 UTC 2023
PRIMARY
NCI_THESAURUS
C48374
Created by admin on Fri Dec 15 17:20:55 UTC 2023 , Edited by admin on Fri Dec 15 17:20:55 UTC 2023
PRIMARY
CAS
857876-30-3
Created by admin on Fri Dec 15 17:20:55 UTC 2023 , Edited by admin on Fri Dec 15 17:20:55 UTC 2023
PRIMARY
PUBCHEM
16097729
Created by admin on Fri Dec 15 17:20:55 UTC 2023 , Edited by admin on Fri Dec 15 17:20:55 UTC 2023
PRIMARY
MERCK INDEX
m7636
Created by admin on Fri Dec 15 17:20:55 UTC 2023 , Edited by admin on Fri Dec 15 17:20:55 UTC 2023
PRIMARY Merck Index
DRUG BANK
DBSALT001987
Created by admin on Fri Dec 15 17:20:55 UTC 2023 , Edited by admin on Fri Dec 15 17:20:55 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of MOTESANIB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966